Log In
BCIQ
Print this Print this
 

DRM02 (formerly QLT418, VAL-002)

  Manage Alerts
Collapse Summary General Information
Company Dermira Inc.
DescriptionTopical phosphodiesterase-4 (PDE-4) inhibitor
Molecular Target Phosphodiesterase-4 (PDE-4)
Mechanism of ActionKinase inhibitor; Phosphodiesterase-4 (PDE-4) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/24/2011

Undisclosed

Undisclosed

0

05/31/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today